John E. Herzenberg, M.D., FRCSC, FAAOS has been appointed to WishBone Medical, Inc.’s Board of Directors.
Dr. John E. Herzenberg Joins WishBone Medical BOD
1 min read Premium comments
Secondary#wishbonemedical#johnherzenberg
Dr. Herzenberg is a board-certified orthopedic surgeon. He specializes in pediatric orthopedics and will use his expertise to support Wishbone Medical in its mission to “provide highly differentiated pediatric orthopedic solutions in single-use, sterile packed procedure kits.”
A leader in his field, Dr. Herzenberg currently serves as the director of pediatric orthopedics at Sinai Hospital, the director of the International Center for Limb Lengthening at the Rubin Institute for Advanced Orthopedics, and a clinical professor at the University of Maryland School of Medicine. He co-founded the Maryland Center for Limb Lengthening & Reconstruction at Kernan Hospital as well as the International Center for Limb Lengthening at Sinai Hospital of Baltimore.
Dr. Herzenberg is world-renowned for his knowledge of the Ponseti Method used to correct congenital clubfoot deformities. WishBone Medical previously welcomed his expertise when he served as a surgeon advisor for the development of WishBone Medical’s Clubfoot Achilles Tenotomy (CAT) Convenience Kit.
OTW spoke with Mark Figgie, M.D., a WishBone Medical board member and surgeon advisor, about the appointment. Dr. Figgie told OTW, “Dr. Herzenberg brings extraordinary knowledge, expertise and innovation to WishBone. Our goal is to continue to develop pediatric appropriate solutions and his experience and vision are unparalleled.”
Dr. Figgie continued, “I am excited to work with him as it is an exceptional opportunity to learn from one of the greatest surgeons and educators in pediatric orthopaedic history.”
WishBone Medical is a global pediatric orthopedic company based in Warsaw, Indiana. It provides “pediatric implants, instruments and solutions in single-use, sterile packed procedure kits.”
In the press release, Dr. Herzenberg commented, “It is a great honor for me to be affiliated with an innovative company that is developing unique and practical solutions to pediatric orthopedic problems, especially within the modern shift to more efficient ambulatory surgery centers.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.